ERS International Congress, Milan 2017

---

Classifying COPD with multidimensional scores and biomarkers

Thematic Poster
Chairs: P. Howarth (Southampton, United Kingdom), A. Papaioannou (Vrilissia, Athens, Greece), F. Schleich (Liège, Belgium), J. Lopez-Campos Bodineau (Sevilla, Spain)

A small-scale trial of home telemonitoring in patients with COPD- The Israeli patient experience A. Bar-Shai (Tel-Aviv, Israel)
GOLD 2011 versus GOLD 2017 – What does change? A. Caldas Marçôa (Matosinhos, Portugal)
Revisiting the role of Spirometry in the diagnosis of upper airway obstruction. D. Laldayal (THRISSUR (KERALA), India)
The use of FENO in COPD: the relationship to pulmonary function tests and its importance in differential diagnosis. E. Dilka (Tirana, Albania)
Association of elevated CRP and IL-6 with rapid decline in lung function and exacerbation in tuberculosis destroyed lung J. Shim (Seoul, Republic of Korea)
The evaluation of home oxygen saturation for prediction of acute exacerbations of COPD. W. Piotrowski (Lódz, Poland)
The Correlation of Serum Brain Natriuretic Peptide and Interlukin-6 with Quality of Life using COPD assessment test H. Ghobadi-Marallu (Ardabil, Islamic Republic of Iran)
What does a highly positive bronchodilator test indicate in a patient with chronic airflow obstruction? M. Cerda (Palma, Spain)
Systemic inflammation, blood eosinophils count and lung function in COPD patients M. Chirea (RAMNICU SARAT/BUZAU, Romania)
Fixed ratio or LLN for defining airflow obstruction in population screening N. Coskun (Bursa, Turkey)
Predicting the clinical outcome in COPD:Who fares thebest-BODE,DOSE or ADO R. NADARAJAN KUMARI (KOLLAM (KERALA), India)
Comparison of Fractional Nitric Oxide in Exhaled Breath in bronchial asthma and COPD S. Mittal (DELHI (NEW DELHI), India)
Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD Y. Kashiwagi (Otsu, Japan)
Atrial fibrillation as a relevant comorbidity in patients with acute exacerbation of chronic obstructive pulmonary disease S. Keymel (DUSSELDORF, Germany)
The impact of the three GOLD severity classifications of COPD (2001, 2011 and 2017) in the same population of patients. S. Moreira (Lisboa, Portugal)
Prospective study of echocardiograpy in chronic obstructive pulmonary disease in tertiary hospital Y. Sheriff (BANGALORE (KARNATAKA), India)
Therapy of COPD based on clinical phenotypes J. Zatloukal (Olomouc, Czech Republic)